GASTROINTESTINAL MALIGNANCY - RATIONALE FOR ADJUVANT THERAPY USING EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY

被引：127

作者：

CUNLIFFE, WJ

SUGARBAKER, PH

机构：

[1] WASHINGTON HOSP CTR, INST CANC, 110 IRVING ST NW, WASHINGTON, DC 20010 USA

[2] UNIV NEWCASTLE UPON TYNE, DEPT SURG, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND

来源：

关键词：

D O I：

10.1002/bjs.1800761030

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：1082 / 1090

页数：9

共 179 条

[11]

BRUCKNER HW, 1982, CANCER TREAT REP, V66, P1713

[12]

BUNCHER CR, 1980, TUMORS PANCREAS, P415

[13]

CASS AW, 1976, CANCER, V37, P2861, DOI 10.1002/1097-0142(197606)37:6<2861::AID-CNCR2820370643>3.0.CO

[14]

2-3

[15]

CELLO JP, 1983, GASTROINTESTINAL DIS, P1514

[16]

CHRISTOPHIDIS N, 1979, CLIN CHEM, V25, P83

CLARKE, JS ;

CRUZE, K ;

ELFARRA, S ;

LONGMIRE, WP .

[18]

CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581

[19]

COLLINS WT, 1952, CANCER, V5, P62, DOI 10.1002/1097-0142(195201)5:1<62::AID-CNCR2820050109>3.0.CO

[20]

2-H